Results 21 to 30 of about 117 (67)

The Peptide MS/MS-Fragmentome: A Set of Predictable Fragment Ions with Highly Redundant Sequence Information [PDF]

open access: yes, 2006
Upon low energy collision induced dissociation (CID), multiply protonated peptides generate a set of interdependent fragment ions detectable by MS/MS, the '[peptide]n+-fragmentome'.
Lehmann, Wolf D.   +3 more
core   +1 more source

S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BASELINE AND IMPROVES THE ACCURACY OF INTERIM PET IN CLASSIC HODGKIN LYMPHOMA

open access: yes, 2022
HemaSphere, Volume 6, Issue S3, Page 126-127, June 2022.
M. C. Pirosa   +41 more
wiley   +1 more source

Long circulating-free DNA fragments predict early-progression (EP) and progression-free-survival (PFS) in advanced carcinoma treated with immune-checkpoint inhibition (ICI): a new biomarker

open access: yes
International audienceBackgroundEstablishing reliable and early predictive biomarkers of response of ICI is essential. Analysis of cfDNA fragmentation profiles (fragmentome) is a promising non-invasive method to do so independently of a specific ...
Boutonnet, Audrey   +8 more
core   +4 more sources

AGE-ASSOCIATED VARIABILITY OF CIRCULATING FREE DNA CHARACTERISTICS: GENOME-WIDE ANALYSIS

open access: yesJournal of Bioinformatics and Genomics
The fragments of circulating free DNA (cfDNA) found in plasma are formed due to the genomic DNA degradation during cellular death. The present study is the first research of age-associated variability of cfDNA characteristics performed on the group of ...
Meshkov I.O.   +13 more
doaj   +1 more source

Early detection of ovarian cancer using cell-free DNA fragmentomes and protein biomarkers. [PDF]

open access: yes
Ovarian cancer is a leading cause of death for women worldwide in part due to ineffective screening methods. In this study, we used whole-genome cell-free DNA (cfDNA) fragmentome and protein biomarker (CA-125 and HE4) analyses to evaluate 591 women with ...
Adleff, Vilmos   +34 more
core   +1 more source

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection [PDF]

open access: yes
Cell-free DNA analysis via methylation and fragmentation profiling has advanced minimally invasive cancer detection; however, broader application has been limited by small cohorts and inconsistent data processing.
Luo, Ping   +27 more
core   +1 more source

Evaluation of cfDNA fragmentation characteristics in plasma for the diagnosis of lung cancer: A prospective cohort study

open access: yesCancer Science, Volume 116, Issue 1, Page 248-256, January 2025.
We constructed a lung cancer detection model using four circulating free DNA (cfDNA) fragmentation features, and this model exhibits strong screening capabilities. It is not only effective for early cancer screening in asymptomatic individuals but also demonstrates robust detection capabilities in early cancer diagnosis.
Fudong Xu   +9 more
wiley   +1 more source

EHA2021 Virtual Congress Abstract Book

open access: yes, 2021
HemaSphere, Volume 5, Issue S2, June 2021.
wiley   +1 more source

Detection of brain cancer using genome-wide cell-free DNA fragmentomes [PDF]

open access: yes
UNLABELLED: Diagnostic delays in patients with brain cancer are common and can impact patient outcome. Development of a blood-based assay for detection of brain cancers could accelerate brain cancer diagnosis.
et al.,, Mathios, Dimitrios
core   +1 more source

Machine learning accurately identifies the fragmentomic signature for DNase1L3 impairment caused by homozygosity for the p.Arg206Cys variant

open access: yesFrontiers in Immunology
DNase1L3 is an endonuclease that fragments DNA during apoptosis and digests DNA from microparticles in plasma, shaping key features of cell-free DNA (cfDNA) and maintaining extracellular DNA homeostasis, a process implicated in autoimmunity.
Jasper Linthorst   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy